Acupuncture may represent an effective adjuvant therapy in the management of joint pain associated with aromatase inhibitor treatment in postmenopausal women with breast cancer.
Intraoperative systemic lidocaine may reduce chronic persistent postmastectomy pain at 6 months after surgery.
The Society for Integrative Oncology has issued an updated clinical practice guideline regarding the use of integrative therapies for specific clinical indications during and after breast cancer treatment.
Aspirin use and cancer has primarily been evaluated by observational studies, which may have substantial bias.
Limited data suggest antidepressants, topical capsaicin, and fat grafting may reduce pain associated with post-mastectomy pain syndrome, but more and better studies are needed to determine optimal management for this debilitating condition.
COX-2 inhibition in the perioperative period does not further reduce persistent pain after breast cancer surgery.
No statistically significant association was found between MTX or anti-TNF use and breast cancer recurrence.
Only patients for whom sentinel lymph node biopsy is positive should undergo axillary dissection
